MONTREAL - February 3, 2020 – SoundBite Medical Solutions Inc. (SBMS) announced today that it has received FDA IDE (Investigational Device Exemption) approval to start the ACTIVE Clinical Study with the SoundBite™...
MONTREAL January 21, 2020 – SoundBite Medical Solutions Inc. (SBMS) today announces it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the SoundBite™ Crossing System, a unique active wire...
MONTREAL December 4, 2019 – SoundBite Medical Solutions Inc. (SBMS) is pleased to announce that it has received a Health Canada Medical Device License for the SoundBite™ Crossing System – Peripheral. “We are...
Asahi Intecc will be Exclusive Japanese Provider of the SoundBite™ Crossing System – Peripheral MONTREAL – December 3, 2019 – SoundBite Medical Solutions Inc. (SBMS) has signed an exclusive distribution agreement with Asahi...
MONTREAL – September 24, 2019 – SoundBite Medical Solutions Inc. (SBMS) today announced that it has entered into an $8 million loan agreement (the “Agreement”) with Investissement Québec (IQ) as part of...
